{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:36:28Z","timestamp":1791765388119,"version":"4.3.4"},"reference-count":24,"publisher":"Japan Atherosclerosis Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,7,1]]},"DOI":"10.5551\/jat.65379","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T22:11:26Z","timestamp":1735078286000},"page":"863-872","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic Factors Associated with 2-year Mortality in Patients with Intermittent Claudication Treated with Endovascular Therapy for Femoropopliteal Lesions: Results from the Multicenter PROCYON Study"],"prefix":"10.5551","volume":"32","author":[{"given":"Tatsuro","family":"Takei","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tenyoukai Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tokuda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya Heart Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ogaki Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sendai Kousei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saiseikai Yokohama City Eastern Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yanagiuchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rakuwakai Otowa Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nakama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the LEADers PAD (peripheral artery disease) investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) White C: Clinical practice. Intermittent claudication. N Engl J Med, 2007; 356: 1241-1250","DOI":"10.1056\/NEJMcp064483"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, McDermott MM, Misra S, Ujueta F, American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Stroke Council: Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: A scientific statement from the American Heart Association. Circulation, 2021; 144: e171-e191","DOI":"10.1161\/CIR.0000000000001005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Iida O, Fujihara M, Kawasaki D, Mori S, Yokoi H, Miyamoto A, Kichikawa K, Nakamura M, Ohki T, Diaz-Cartelle J, M\u00fcller-H\u00fclsbeck S, Gray WA, and Soga Y: 24-month efficacy and safety results from Japanese patients in the IMPERIAL randomized study of the eluvia drug-eluting stent and the zilver PTX drug-coated stent. Cardiovasc Intervent Radiol, 2021; 44: 1367-1374","DOI":"10.1007\/s00270-021-02901-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, Yamauchi Y, Tobita K, Kozuki A, Fujihara M, Ando K, and POPCORN Investigators: Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. J Am Heart Assoc, 2023; 12: e025677","DOI":"10.1161\/JAHA.122.025677"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, Rand T, Funovics M, Wolf F, Rastan A, Gschwandtner M, Puchner S, Ristl R, and Schoder M: Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol, 2013; 62: 1320-1327","DOI":"10.1016\/j.jacc.2013.05.079"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Scheinert D, Werner M, Scheinert S, Paetzold A, Banning-Eichenseer U, Piorkowski M, Ulrich M, Bausback Y, Br\u00e4unlich S, and Schmidt A: Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry. JACC Cardiovasc Interv, 2013; 6: 65-71","DOI":"10.1016\/j.jcin.2012.09.011"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Criqui MH and Aboyans V: Epidemiology of peripheral artery disease. Circ Res, 2015; 116: 1509-1526. Erratum in: Circ Res, 2015; 117: e12","DOI":"10.1161\/CIRCRESAHA.116.303849"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, and TASC II Working Group: Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg, 2007; 45: S5-S67","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Steg PG, Bhatt DL, Wilson PWF, D\u2019Agostino R Sr, Ohman EM, R\u00f6ther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S, and REACH Registry Investigators: One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA, 2007; 297: 1197-1206","DOI":"10.1001\/jama.297.11.1197"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Takahara M, Soga Y, and Iida O: Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization. Eur Heart J, 2024; 45: 1634-1643","DOI":"10.1093\/eurheartj\/ehae207"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Wong PF, Chong LY, Mikhailidis DP, Robless P, and Stansby G: Antiplatelet agents for intermittent claudication. Cochrane Database Syst Rev, 2011; 11: CD001272","DOI":"10.1002\/14651858.CD001272.pub2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Baubeta Fridh E, Andersson M, Thuresson M, Sigvant B, Kragsterman B, Johansson S, Hasvold P, Falkenberg M, and Nordanstig J: Amputation rates, mortality, and pre-operative comorbidities in patients revascularised for intermittent claudication or critical limb ischaemia: A population based study. Eur J Vasc Endovasc Surg, 2017; 54: 480-486","DOI":"10.1016\/j.ejvs.2017.07.005"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kotov A, Blasche DA, Peters F, Pospiech P, Rother U, Stavroulakis K, Remig J, Schmidt-Lauber C, Zeller T, G\u00f6rtz H, Te\u00dfarek J, and Behrendt CA: The impact of chronic kidney disease on mid-term outcomes after revascularisation of peripheral arterial occlusive disease: results from a prospective cohort study. J Clin Med, 2022; 11: 4750","DOI":"10.3390\/jcm11164750"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Himmelfarb J, Vanholder R, Mehrotra R, and Tonelli M: The current and future landscape of dialysis. Nat Rev Nephrol, 2020; 16: 573-585","DOI":"10.1038\/s41581-020-0315-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Singh S, Bailey KR, Noheria A, and Kullo IJ: Frailty across the spectrum of ankle-brachial index. Angiology, 2012; 63: 229-236","DOI":"10.1177\/0003319711413457"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) McDermott MM, Liu K, Tian L, Guralnik JM, Criqui MH, Liao Y, and Ferrucci L: Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study. J Am Coll Cardiol, 2012; 59: 1159-1167","DOI":"10.1016\/j.jacc.2011.12.019"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Matsuo Y, Kumakura H, Kanai H, Iwasaki T, and Ichikawa S: The geriatric nutritional risk index predicts long-term survival and cardiovascular or limb events in peripheral arterial disease. J Atheroscler Thromb, 2020; 27: 134-143","DOI":"10.5551\/jat.49767"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Cho I, Chang HJ, Sung JM, Pencina MJ, Lin FY, Dunning AM, Achenbach S, Al-Mallah M, Berman DS, Budoff MJ, Callister TQ, Chow BJW, Delago A, Hadamitzky M, Hausleiter J, Maffei E, Cademartiri F, Kaufmann P, Shaw LJ, Raff GL, Chinnaiyan KM, Villines TC, Cheng V, Nasir K, Gomez M, Min JK, and CONFIRM Investigators: Coronary computed tomographic angiography and risk of all-cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the CONFIRM Registry (coronary CT angiography evaluation for clinical outcomes: an international multicenter registry). Circulation, 2012; 126: 304-313","DOI":"10.1161\/CIRCULATIONAHA.111.081380"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Gupta DK, Skali H, Claggett B, Kasabov R, Cheng S, Shah AM, Loehr LR, Heiss G, Nambi V, Aguilar D, Wruck LM, Matsushita K, Folsom AR, Rosamond WD, and Solomon SD: Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (Atherosclerosis Risk In Communities). JACC Heart Fail, 2014; 2: 447-454","DOI":"10.1016\/j.jchf.2014.05.008"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Smolderen KG, Romain G, Provance JB, Scierka LE, Mao J, Goodney PP, Henke PK, Sedrakyan A, and Mena-Hurtado C: Guideline-directed medical therapy and long-term mortality and amputation outcomes in patients undergoing peripheral vascular interventions. JACC Cardiovasc Interv, 2023; 16: 332-343","DOI":"10.1016\/j.jcin.2022.09.022"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sigvant B, Kragsterman B, Falkenberg M, Hasvold P, Johansson S, Thuresson M, and Nordanstig J: Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization. J Vasc Surg, 2016; 64: 1009-1017.e3","DOI":"10.1016\/j.jvs.2016.03.429"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, and Walsh ME: AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines. Circulation, 2017; 135: e726-e779","DOI":"10.1161\/CIR.0000000000000471"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Sohn M and Lim S: The role of cilostazol, a Phosphodiesterase-3 inhibitor, in the development of atherosclerosis and vascular biology: a review with meta-analysis. Int J Mol Sci, 2024; 25: 2593","DOI":"10.3390\/ijms25052593"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kalantzi K, Tentolouris N, Melidonis AJ, Papadaki S, Peroulis M, Amantos KA, Andreopoulos G, Bellos GI, Boutel D, Bristianou M, Chrisis D, Dimitsikoglou NA, Doupis J, Georgopoulou C, Gkintikas SA, Iraklianou S, Kanellas \u039a, Kotsa K, Koufakis T, Kouroglou M, Koutsovasilis AG, Lanaras L, Liouri E, Lixouriotis C, Lykoudi A, Mandalaki E, Papageorgiou E, Papanas N, Rigas S, Stamatelatou MI, Triantafyllidis I, Trikkalinou A, Tsouka AN, Zacharopoulou O, Zoupas C, Tsolakis I, and Tselepis AD: Efficacy and safety of adjunctive cilostazol to clopidogrel-treated diabetic patients with symptomatic lower extremity artery disease in the prevention of ischemic vascular events. J Am Heart Assoc, 2021; 10: e018184","DOI":"10.1161\/JAHA.120.018184"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/7\/32_65379\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T03:45:32Z","timestamp":1751687132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/7\/32_65379\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65379","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"article-number":"65379"}}